Learn More
Genscript Corporation CHO-K1/Spike Stable Cell Line
Supplier: Genscript Corporation M00803

Recombinant CHO-K1 cells stably overexpress human SARS-CoV-2 spike protein on their surface The surface expression of SARS-CoV-2 spike protein is validated by FACS analysis This stable cell line product is designed for screening antibodies against the SARS-CoV-2 spike protein as well as measuring binding affinity and stability of antibody-based biologics that bind with spike protein GenScript also offers spike protein expressing HEK293T stable cell line (Cat No M00804) for SARS-CoV-2 study
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.